XML 44 R32.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Stockholders’ Equity [Abstract] |
Schedule of Activities of Warrants that were Issued from Equity Financing | Following is a summary of the activities of warrants that were issued from equity financing for the year ended March 31, 2026:
|  | Number of Warrants |  |  | Average Exercise Price |  |  | Weighted Average Remaining Contractual Term in Years |
Outstanding at January 1, 2025 |  |  | 1,652 |  |  |  | 100 |  |  |  | - |
Exercisable at January 1, 2025 |  |  | 1,652 |  |  |  | 100 |  |  |  | - |
Granted |  |  | 234 |  |  |  | 100 |  |  |  | - |
Exchanged |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | (1,652 | ) |  |  | 100 |  |  |  | - |
Outstanding at December 31, 2025 |  |  | 234 |  |  |  | 100 |  |  |  | - |
Exercisable at December 31, 2025 |  |  | 234 |  |  |  | 100 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Exchanged |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2026 |  |  | 234 |  |  |  | 100 |  |  |  | - |
Exercisable at March 31, 2026 |  |  | 234 |  |  |  | 100 |  |  |  | - |

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration